Key result
Congestive heart failure and a larger left atrial appendage orifice diameter were identified as significant predictors for the occurrence of pericardial effusion following LAmbre device implantation.
Why the study?
Pericardial effusion is an uncommon but serious complication after percutaneous LAAC, but few data exist regarding its occurrence following implantation of the LAmbre device.
Cohort (n=133)
No
Pericardial effusion is an uncommon complication (4.5%) following LAmbre device implantation, with congestive heart failure and larger LAA orifice diameter identified as significant predictors.
Answers are grounded in this paper and cite their sources.
Patients with CHF or larger LAA orifice may warrant heightened post-LAmbre monitoring; leaves open prospective validation before guiding risk stratification.
Background Pericardial effusion (PE) is an uncommon but serious complication that occurs following percutaneous left atrial appendage closure (LAAC). There are few data regarding PE following implantation of the LAmbre device for LAAC. Methods Patients with nonvalvular atrial fibrillation (AF) undergoing percutaneous LAAC using the LAmbre device at the Arrhythmia Center of Ningbo First Hospital from October 2017 to March 2021 were retrospectively reviewed (n = 133). PE was defined as acute if diagnosed ≤7 days post LAAC (n = 3, 2.3%) or delayed if diagnosed >7 days post LAAC (n = 3, 2.3%). The clinical characteristics and procedural data were compared between patients with PE (PE group, n = 6) and without PE (non-PE group, n = 127). The predictors of PE were analyzed by logistic regression. Results All patients with PE recovered following treatment by pericardiocentesis. Patients with PE were found to have a higher incidence of congestive heart failure (50.0% vs. 13.4%, P = 0.044) and had larger measured LAA orifice diameters (33.5 mm ± 6.0 mm vs. 28.3 mm ± 5.2 mm, P = 0.018) and landing zone diameters (27.8 mm ± 4.8 mm vs. 23.9 mm ± 4.8 mm, P = 0.054) compared with those without PE. The diameters of the device umbrellas (31.7 mm ± 5.6 mm vs. 26.9 mm ± 5.0 mm, P = 0.026) and covers (36.3 mm ± 4.6 mm vs. 33.4 mm ± 4.0 mm, P = 0.075) implanted were larger in the PE group compared to the non-PE group. Univariate logistic regression revealed that congestive heart failure (OR = 6.47, 95% CI = 1.21–34.71, P = 0.029) and LAA maximal orifice diameter (OR = 1.22, 95% CI = 1.02–1.45, P = 0.027) were both associated with PE following LAmbre device implantation. Conclusions In this single-center experience, both acute and delayed PE were uncommon in patients with AF following LAmbre device implantation. Congestive heart failure and a larger LAA orifice were identified as predictors for the occurrence of PE.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2023) conducted a cohort in Nonvalvular atrial fibrillation (n=133). Congestive heart failure vs. No congestive heart failure was evaluated on Pericardial effusion following LAmbre device implantation (OR 6.47, 95% CI 1.21-34.71, p=0.029). Congestive heart failure and a larger left atrial appendage orifice diameter were identified as significant predictors for the occurrence of pericardial effusion following LAmbre device implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: